• Skip to content
  • Skip to footer
Therachon

Therachon

  • About Us
    • Management Team
    • Board of Directors
    • Partners
  • Our Focus
    • Achondroplasia
    • Short Bowel Syndrome
    • Pipeline
  • News & Media
  • Contact Us

News & Media

News & Media
Therachon Appoints Dr. Maarten Kraan, Ph.D., M.D., Chief Medical Officer

March 21, 2017

Therachon Appoints Dr. Maarten Kraan, Ph.D., M.D., Chief Medical Officer

Basel, Switzerland – March 21, 2017 – THERACHON AG, a biotechnology company focused on rare genetic diseases, announced today it has appointed Dr. Maarten Kraan, Ph.D., M.D., to the role of…

Therachon Appoints Industry Leaders to Board of Directors, Top Management Roles

February 15, 2017

Therachon Appoints Industry Leaders to Board of Directors, Top Management Roles

Basel, Switzerland – February 15, 2017 – THERACHON AG, a biotechnology company focused on rare genetic diseases, announced today the strengthening of its Board of Directors and executive management team. Hans Schikan,…

Therachon Appoints Luca Santarelli, M.D., as Chief Executive Officer and Extends Series A Financing

January 5, 2017

Therachon Appoints Luca Santarelli, M.D., as Chief Executive Officer and Extends Series A Financing

Basel, Switzerland – Jan. 5, 2017 – Therachon AG, a biotechnology company focused on rare genetic diseases, today announced it has appointed Luca Santarelli, M.D., as Chief Executive Officer and Director,…

  • « Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4

Footer

  • About Us
  • Our Focus
  • Contact Us
  • News & Media
  • Join Us
Therachon logo

Terms of Use | Privacy Policy

Copyright © Therachon. 2019 All Rights Reserved.